Biotech Daily

Daily news on ASX-listed biotechnology companies

Subscribe to Biotech Daily

Biotech Daily covers the major announcements from ASX-listed biotech companies as well as developments in government policy and regulation.

Published shortly after the stock market closes five days a week - excluding public holidays - Biotech Daily is the only comprehensive daily source of information on the listed biotech sector.

A Top 40 of the more than 140 listed companies is constantly monitored for clinical development and price sensitive announcements and published via direct subscription.

2024 base level subscriptions are $A2050 a year (including GST in Australia).

Subscribers include biotech directors, CEOs and CFOs, research institutes, investment houses, market analysts, legal and IP specialists, medical specialists and hospital management.

Please fill in the subscription form below.

Subscription form

Base subscription

$A2,050.00 (including Australian GST) for 12 months subscription for up to three email addresses


Contact details


Included email addresses for newsletter delivery

Please use bottom field to add 4+ recipients

Please supply extra recipient names and email addresses below
One name and email per line please

Payment options

Domestic payment

(Within 14 days) by electronic transfer to:

Bank Australia (account of Biotech Daily)

BSB: 313-140
Account No: 122-045-90

Off-shore payment

By electronic transfer to:

Bendigo Bank (account of Biotech Daily)

BSB: 633-000
Account No: 127-195-550
SWIFT Code: BENDAU3B

Please ensure the invoice number and name/ASX code are in the “reference” line.

© Copyright 2007-2022. All Rights Reserved. Biotech Daily, PO Box 5000, Carlton, Victoria

TOP